Osteoporosis caused by portosystemic shunting [16], or by steroid or CIs through receptor activator of nuclear factor kappa-B ligand (RANKL)-dependent pathways, may be partially ameliorated using sirolimus [17]. This evidence concerns the gene TNFSF11 and osteoporosis.